Cargando…
Phage-Derived Depolymerase: Its Possible Role for Secondary Bacterial Infections in COVID-19 Patients
As of 29 July 2022, there had been a cumulative 572,239,451 confirmed cases of COVID-19 worldwide, including 6,390,401 fatalities. COVID-19 patients with severe symptoms are usually treated with a combination of virus- and drug-induced immuno-suppression medicines. Critical clinical complications of...
Autores principales: | Nazir, Amina, Song, Jiaoyang, Chen, Yibao, Liu, Yuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961776/ https://www.ncbi.nlm.nih.gov/pubmed/36838389 http://dx.doi.org/10.3390/microorganisms11020424 |
Ejemplares similares
-
Potential of phage depolymerase for the treatment of bacterial biofilms
por: Guo, Zhimin, et al.
Publicado: (2023) -
Therapeutic Application of Bacteriophage PHB02 and Its Putative Depolymerase Against Pasteurella multocida Capsular Type A in Mice
por: Chen, Yibao, et al.
Publicado: (2018) -
Phage Endolysins: Advances in the World of Food Safety
por: Nazir, Amina, et al.
Publicado: (2023) -
Diversity and Function of Phage Encoded Depolymerases
por: Knecht, Leandra E., et al.
Publicado: (2020) -
Phage Engineering for Targeted Multidrug-Resistant Escherichia coli
por: Song, Jiaoyang, et al.
Publicado: (2023)